ES2115543B1 - Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma. - Google Patents

Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.

Info

Publication number
ES2115543B1
ES2115543B1 ES9601755A ES9601755A ES2115543B1 ES 2115543 B1 ES2115543 B1 ES 2115543B1 ES 9601755 A ES9601755 A ES 9601755A ES 9601755 A ES9601755 A ES 9601755A ES 2115543 B1 ES2115543 B1 ES 2115543B1
Authority
ES
Spain
Prior art keywords
procedure
carbetocine
complexes
obtaining
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9601755A
Other languages
English (en)
Other versions
ES2115543A1 (es
Inventor
Rodriguez Fco Javier Clemente
Obiols Berta Ponsati
Duena Antonio Parente
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BCN Peptides SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Priority to ES9601755A priority Critical patent/ES2115543B1/es
Publication of ES2115543A1 publication Critical patent/ES2115543A1/es
Application granted granted Critical
Publication of ES2115543B1 publication Critical patent/ES2115543B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE CARBETOCINA Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES O COMPLEJOS DE LA MISMA. CONSISTE EN UN PROCEDIMIENTO SIMPLE DE SINTESIS EN FASE SOLIDA QUE CONSTA DE: 1) CONSTRUCCION DE LA ESTRUCTURA LINEAL CON LA INCORPORACION DEL ACIDO 4-CLOROBUTIRICO EN EL EXTREMO AMINO TERMINAL. 2) DESPROTECCION DEL GRUPO TIOL DE LA CISTEINA Y SIMULTANEA ROTURA DEL ENLACE PEPTIDO RESINA. 3) CICLACION INTRAMOLECULAR EN MEDIO BASICO POR ATAQUE NUCLEOFILO DEL GRUPO S- SOBRE EL GRUPO CL PARA FORMAR EL ENLACE TIOETER.
ES9601755A 1996-08-06 1996-08-06 Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma. Expired - Fee Related ES2115543B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9601755A ES2115543B1 (es) 1996-08-06 1996-08-06 Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9601755A ES2115543B1 (es) 1996-08-06 1996-08-06 Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.

Publications (2)

Publication Number Publication Date
ES2115543A1 ES2115543A1 (es) 1998-06-16
ES2115543B1 true ES2115543B1 (es) 1999-02-16

Family

ID=8295767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9601755A Expired - Fee Related ES2115543B1 (es) 1996-08-06 1996-08-06 Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.

Country Status (1)

Country Link
ES (1) ES2115543B1 (es)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103467573A (zh) * 2013-09-02 2013-12-25 深圳翰宇药业股份有限公司 一种卡贝缩宫素的制备方法
CN103992390A (zh) * 2013-09-10 2014-08-20 杭州诺泰制药技术有限公司 一种合成卡贝缩宫素的方法
CN104592362A (zh) * 2015-01-05 2015-05-06 苏州天马医药集团天吉生物制药有限公司 卡贝缩宫素的合成工艺
CN112094324A (zh) * 2020-09-21 2020-12-18 宁波三生生物科技有限公司 一种卡贝缩宫素的合成方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103833831B (zh) * 2013-10-22 2015-11-25 海南双成药业股份有限公司 一种卡贝缩宫素的制备方法
CN112142825B (zh) * 2020-10-13 2022-03-11 山东辰龙药业有限公司 片段方式合成卡贝缩宫素的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS270051B1 (cs) * 1988-06-03 1990-06-13 Lebl Michal Analogy oxytocinu
CS103091A3 (en) * 1991-04-12 1992-10-14 Ustav Organicke Chemie A Bioch Protected substituted benzhydrylamines as shoulders for the synthesis ofpeptides on solid phase, process of their preparation and use
ES2055665B1 (es) * 1993-02-03 1995-03-01 Lipotec Sa Procedimiento para la obtencion de carbocalcitonina.

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103467573A (zh) * 2013-09-02 2013-12-25 深圳翰宇药业股份有限公司 一种卡贝缩宫素的制备方法
CN103467573B (zh) * 2013-09-02 2017-12-15 深圳翰宇药业股份有限公司 一种卡贝缩宫素的制备方法
CN103992390A (zh) * 2013-09-10 2014-08-20 杭州诺泰制药技术有限公司 一种合成卡贝缩宫素的方法
CN104592362A (zh) * 2015-01-05 2015-05-06 苏州天马医药集团天吉生物制药有限公司 卡贝缩宫素的合成工艺
CN112094324A (zh) * 2020-09-21 2020-12-18 宁波三生生物科技有限公司 一种卡贝缩宫素的合成方法
CN112094324B (zh) * 2020-09-21 2022-05-03 宁波三生生物科技股份有限公司 一种卡贝缩宫素的合成方法

Also Published As

Publication number Publication date
ES2115543A1 (es) 1998-06-16

Similar Documents

Publication Publication Date Title
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
NO20026252D0 (no) AZA-broforbundet - bicykliske aminosyrederivater som alfa 4 integrin antagonister
AR034456A1 (es) Champues con alcohol de behenilo
DK1178958T3 (da) N-cyanomethylamider som proteaseinhibitorer
TW200613290A (en) Substituted urea compounds
BR0012243A (pt) Triflúor butenos nematocidas
CY1108559T1 (el) Αλατα βαλσαρτανης
BR0317822A (pt) Composição fluoroquìmica
CY1107506T1 (el) Μεθοδος για σταθεροποιηση ενωσεων βενζιμιδαζολης
MEP39108A (en) Pharmaceutical composition
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
CY1108085T1 (el) Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπ-2-εν-1-ονης παρασκευη και χρησης αυτων
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
EA200200938A1 (ru) Фармацевтические композиции, содержащие производные азетидина, новые производные азетидина и их получение
ES2161049T3 (es) Composicion farmaceutica para administracion oral de un derivado de la n-piperidino-3-pirazolcarboxamida, de sus sales y de sus solvatos.
CY1108549T1 (el) Συνθετικες μεθοδοι για απλιδινη και νεα κατα του ογκου παραγωγα, μεθοδοι κατασκευης και χρησης αυτων
BR0110246A (pt) Amidas de ácido benzóico substituìdas e uso das mesmas para inibição de angiogênese
UY26780A1 (es) Cicloalquil avb3 antagonistas
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
TR200201683T2 (tr) İkameli fenil-piperazin türevleri, bunların hazırlanması ve kullanımları
ES2115543B1 (es) Procedimiento para la obtencion de carbetocina y sus sales de adicion de acido farmaceuticamente aceptables o complejos de la misma.
BR9916887A (pt) Uso de derivados de pirimidina
CY1105165T1 (el) Φαρμακευτικη συνθεση που πepιλαμβανει συνδυασμο μετφορμινης και 4-οξοβουτανικου οξεος και η χρηση αυτης για τη θepαπεια του διαβητη
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
YU87501A (sh) Farmaceutski kompleksi

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980616

Kind code of ref document: A1

Effective date: 19980616

PC2A Transfer of patent

Owner name: BCN PEPTIDES, S.A.

Effective date: 20120905

FD2A Announcement of lapse in spain

Effective date: 20161125